EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole Heart Dose Parameters Predict Severe Arrhythmias After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Competing Risk Analysis of 358 Patients

Wei-Xiang Qi iD, Haiping Zhang, Xunmei Yang, Shuyan Li, Mengdi Wang, Biao Yu, Linlin Chen, Gang Cai, Cheng Xu, Jiayi Chen, Shengguang Zhao iD

Cancer Medicine · 2026

DOI: 10.1002/cam4.71610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Wei-Xiang Qi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Arrhythmias, Cardiac, Esophageal Neoplasms, Neoadjuvant Therapy, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Science and Technology Innovation Action Plan, Shanghai Science and Technology Innovation Action Plan Medical Innovation Research Project, Clinical Research Special Project of Shanghai Municipal Health Commission Health Industry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dose exposure to supraventricular cardiac conduction system doses has been reported to be associated with distinct arrhythmia classes after thoracic radiotherapy, but its impact in esophageal squamous cell carcinoma (ESCC) remains unknown. Materials and Methods Locally advanced ESCC treated with neoadjuvant chemoradiotherapy (nCRT) were included. The primary endpoint was grade ≥ 3 adverse cardiac arrhythmia events. Prediction performance was evaluated through time‐dependent receiver operating characteristic curves, and competing risk frameworks were implemented to quantify the cumulative incidence of distinct cardiac arrhythmia.

Results

Of 358 patients, 84.9% were men, with a median age of 66 years (range: 39–79 years). A total of 60 (16.8%) patients experienced at least 1 grade ≥ 3 arrhythmia, with a median time to first arrhythmia of 13 months (95% CI: 12–15 months). The 2‐year cumulative incidences of distinct cardiac arrhythmia were 8.89% for AF, 2.96% for atrial flutter, and 5.12% for other SVT. Baseline coronary heart disease was a risk factor for all types of arrhythmia ( p < 0.05). After adjusting for baseline cardiovascular risk factors, Heart D max (sHR 3.69, p = 0.0024) was associated with AF, Heart volume receiving 5 Gy with atrial flutter (sHR: 9.35, p = 0.0077), and Heart volume receiving 40 Gy (sHR 5.72, p = 0.00078) with other SVT.

Conclusion

Grade ≥ 3 cardiac arrhythmia associated with thoracic radiation occurs in 16.7% of ESCC patients undergoing nCRT within a median time of 13 months. The radiation dose exposure of the supraventricular cardiac conduction system is not associated with increased cardiac arrhythmia. Specific arrhythmia subtypes exhibited differential associations with distinct dose‐volume parameters of whole heart irradiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arrhythmias, CardiacEsophageal NeoplasmsNeoadjuvant TherapyEsophageal Squamous Cell CarcinomaHeartChemoradiotherapyHumansMaleAgedMiddle AgedAdultFemaleRisk AssessmentRadiotherapy DosageRisk FactorsIncidence

Stichwörter der Autor:innen

arrhythmiacardiac toxicitiesesophageal cancerneoadjuvant chemoradiotherapysupraventricular cardiac conduction system

Autor:innen und Institutionen

  • Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory of Proton-Therapy, Shanghai, China.
  • Department of Medical Oncology, Linfen People's Hospital, Linfen, China.
  • Department of Oncology, People's Hospital of Qiandongnan Miao and Dong Autonomous Prefecture, Kaili, China.

ORCID-Profile: Wei-Xiang Qi, Shengguang Zhao

Förderung

  • Shanghai Science and Technology Innovation Action Plan
  • Shanghai Science and Technology Innovation Action Plan Medical Innovation Research Project
  • Clinical Research Special Project of Shanghai Municipal Health Commission Health Industry
  • the National Key Research and Development Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Qi, W. X., Zhang, H., Yang, X., Li, S., Wang, M., Yu, B., Chen, L., Cai, G., Xu, C., Chen, J., & Zhao, S. (2026). Whole Heart Dose Parameters Predict Severe Arrhythmias After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Competing Risk Analysis of 358 Patients. Cancer Medicine. https://doi.org/10.1002/cam4.71610

Vancouver

Qi WX, Zhang H, Yang X, Li S, Wang M, Yu B, et al. Whole Heart Dose Parameters Predict Severe Arrhythmias After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Competing Risk Analysis of 358 Patients. Cancer Medicine. 2026. doi:10.1002/cam4.71610

BibTeX
@article{Qi2026,
  author = {Qi, Wei-Xiang and Zhang, Haiping and Yang, Xunmei and Li, Shuyan and Wang, Mengdi and Yu, Biao and Chen, Linlin and Cai, Gang and Xu, Cheng and Chen, Jiayi and Zhao, Shengguang},
  title = {Whole Heart Dose Parameters Predict Severe Arrhythmias After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Competing Risk Analysis of 358 Patients},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71610}
}
Kostenlos starten →